Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Integrated Telehealth or In-Person Palliative Care in Improving Quality of Life in Patients with Advanced Non-small Cell Lung Cancer

This randomized clinical trial studies how well integrated telehealth or in-person palliative care works in improving quality of life in patients with non-small lung cancer that has spread to other places in the body. Early involvement in palliative care may lesson many of the distressing physical and emotional symptoms and help patients and their families cope with serious illness as well as improve patients’ and their loved ones’ experience with cancer. Integrated telehealth palliative care involves patients meeting with palliative care clinicians using secure video-conferencing technology. It is not yet known whether giving integrated telehealth or in-person palliative care works better for patients and their families in improving quality of life.
Lung, Non Small Cell
N/A
Adults
Not Available
Not Available
Martin, Sara
National
Vanderbilt University
05-16-2018
Supportive Care
VICCTHO1839
NCT03375489

Eligibility

18 Years
BOTH
YES
Inclusion Criteria:

PATIENT: Diagnosed with advanced non-small cell lung carcinoma (NSCLC) being treated with non-curative intent, and informed of advanced disease within the prior twelve weeks

PATIENT: Eastern Cooperative Oncology Group (ECOG) performance status from 0 (asymptomatic) to 3 (symptomatic and in bed > 50% of the day)

PATIENT: The ability to read and respond to questions in English or Spanish

PATIENT: Receiving primary cancer care at one of the participating sites

CAREGIVER: Relative or friend who is identified by the patient participant and lives with the patient or has contact with them at least twice per week

CAREGIVER: The ability to read and respond to questions in English or Spanish



Exclusion Criteria:

PATIENT: They are already receiving outpatient PC or hospice services

PATIENT: They have cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation

CAREGIVER: They have cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: